The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map
Open accessPublished version of a preprint
Abstract
The application of RNA interference (RNAi) to mammalian cells has provided the means to perform phenotypic screens to determine the functions of genes. Although RNAi has revolutionized loss-of-function genetic experiments, it has been difficult to systematically assess the prevalence and consequences of off-target effects. The Connectivity Map (CMAP) represents an unprecedented resource to study the gene expression consequences of expressing short hairpin RNAs (shRNAs). Analysis of signatures for over 13,000 shRNAs applied in 9 cell lines revealed that microRNA (miRNA)-like off-target effects of RNAi are far stronger and more pervasive than generally appreciated. We show that mitigating off-target effects is feasible in these datasets via computational methodologies to produce a consensus gene signature (CGS). In addition, we compared RNAi technology to clustered regularly interspaced short palindromic repeat (CRISPR)-based knockout by analysis of 373 single guide RNAs (sgRNAs) in 6 cells lines and show that the on-target efficacies are comparable, but CRISPR technology is far less susceptible to systematic off-target effects. These results will help guide the proper use and analysis of loss-of-function reagents for the determination of gene function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Self-citationMolecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
Self-citationA Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
Self-citationHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 1×
“3 promiscuity of Cas9 from Streptococcus pyogenes has varied widely [31,32] .”
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Identification and characterization of essential genes in the human genome
Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M. (2015) · Science · doi:10.1126/science.aac7041 · Cited by 1,617
Koike-Yusa, H., Li, Y., Tan, E.-P., Velasco-Herrera, M. D. C., & Yusa, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2800 · Cited by 1,064
Treatment of Obesity with Celastrol
Liu, J., Lee, J., Salazar Hernandez, M. A., Mazitschek, R., & Ozcan, U. (2015) · Cell · doi:10.1016/j.cell.2015.05.011 · Cited by 726
Veres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474
Kunkel, S. D., Suneja, M., Ebert, S. M., Bongers, K. S., Fox, D. K., Malmberg, S. E., Alipour, F., Shields, R. K., & Adams, C. M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.020 · Cited by 345 · cited 1×
“Even with this limited-scale dataset, query of CMAP has provided biological insight across diverse disease areas [6-9].”
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191
Self-citation
Research works printed but not linked: 34
- J Lamb, 2006, The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, Science. American Association for the Advancement of Science, 313, 1929, 10.1126/science.1132939 · DOI · Paper page
- V Belcastro, 2011, Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene function, Nucleic Acids Research, 39, 8677, 10.1093/nar/gkr593 · DOI
- Z Wang, 2016, Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd, Nature Communications. Nature Publishing Group, 7, 12846, 10.1038/ncomms12846 · DOI · Paper page
- L Pirhaji, 2016, Revealing disease-associated pathways by network integration of untargeted metabolomics, Nature Methods. Nature Research, 13, 770, 10.1038/nmeth.3940 · DOI · Paper page
- CK Hahn, 2009, Proteomic and Genetic Approaches Identify Syk as an AML Target, Cancer Cell. Elsevier Ltd, 16, 281, 10.1016/j.ccr.2009.08.018 · DOI · Paper page
- CJ Echeverri, 2006, Minimizing the risk of reporting false positives in large-scale RNAi screens, Nature Methods, 3, 777, 10.1038/nmeth1006-777 · DOI · Paper page
- PJ Paddison, 2004, A resource for large-scale RNA-interference-based screens in mammals, Nature, 428, 427, 10.1038/nature02370 · DOI · Paper page
- K Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature, 428, 431, 10.1038/nature02371 · DOI · Paper page
- J Moffat, 2006, A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen, Cell, 124, 1283, 10.1016/j.cell.2006.01.040 · DOI · Paper page
- L Cong, 2013, Multiplex Genome Engineering Using CRISPR/Cas Systems, Science, 339, 819, 10.1126/science.1231143 · DOI · Paper page
- M Jinek, 2013, RNA-programmed genome editing in human cells, eLife, 2, e00471, 10.7554/eLife.00471 · DOI · Paper page
- M Jinek, 2012, A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity, Science, 337, 816, 10.1126/science.1225829 · DOI · Paper page
- T Wang, 2014, Genetic Screens in Human Cells Using the CRISPR-Cas9 System, Science, 343, 80, 10.1126/science.1246981 · DOI · Paper page
- JG Doench, 2003, siRNAs can function as miRNAs, Genes Dev, 17, 438, 10.1101/gad.1064703 · DOI · Paper page
- FD Sigoillot, 2012, A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens, Nature Methods, 9, 363, 10.1038/nmeth.1898 · DOI · Paper page
- WG Kaelin, 2012, Molecular biology. Use and abuse of RNAi to study mammalian gene function, Science, 337, 421, 10.1126/science.1225787 · DOI · Paper page
- DS Schwarz, 2003, Asymmetry in the assembly of the RNAi enzyme complex, Cell, 115, 199, 10.1016/S0092-8674(03)00759-1 · DOI · Paper page
- SRV Knott, 2014, A Computational Algorithm to Predict shRNA Potency, Mol Cell, 56, 796, 10.1016/j.molcel.2014.10.025 · DOI
- SW Chi, 2009, Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps, Nature, 460, 479, 10.1038/nature08170 · DOI · Paper page
- D Peck, 2006, A method for high-throughput gene expression signature analysis, Genome Biol, 7, R61, 10.1186/gb-2006-7-7-r61 · DOI · Paper page
- S Guda, 2015, miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction, Mol Ther, 23, 1465, 10.1038/mt.2015.113 · DOI
- S Singh, 2015, Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects, PLoS ONE, 10, e0131370, 10.1371/journal.pone.0131370 · DOI
- FD Sigoillot, 2011, Vigilance and Validation: Keys to Success in RNAi Screening, ACS Chem Biol, 6, 47, 10.1021/cb100358f · DOI
- A Tsherniak, 2017, Defining a Cancer Dependency Map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 · DOI · Paper page
- O Alter, 2000, Singular value decomposition for genome-wide expression data processing and modeling, Proc Natl Acad Sci USA, 97, 10101, 10.1073/pnas.97.18.10101 · DOI · Paper page
- E Buehler, 2012, C911: A bench-level control for sequence specific siRNA off-target effects, PLoS ONE, 7, e51942, 10.1371/journal.pone.0051942 · DOI
- JG Doench, 2014, Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation, Nat Biotechnol, 32, 1262, 10.1038/nbt.3026 · DOI · Paper page
- AJ Aguirre, 2016, Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting, Cancer Discovery, 6, 914, 10.1158/2159-8290.CD-16-0154 · DOI · Paper page
- DM Munoz, 2016, CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions, Cancer Discovery, 6, 900, 10.1158/2159-8290.CD-16-0178 · DOI · Paper page
- DD Shao, 2013, ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens, Genome Research, 23, 665, 10.1101/gr.143586.112 · DOI
- Q Duan, 2016, L1000CDS(2): LINCS L1000 characteristic direction signatures search engine, NPJ Syst Biol Appl, 2, 257, 10.1038/npjsba.2016.15 · DOI · Paper page
- C Fellmann, 2011, Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor Assay, Mol Cell. Elsevier Inc, 41, 733, 10.1016/j.molcel.2011.02.008 · DOI · Paper page
- C Watanabe, 2016, Quantitative evaluation of first, second, and third generation hairpin systems reveals the limit of mammalian vector-based RNAi, RNA Biol. Taylor & Francis, 13, 25, 10.1080/15476286.2015.1128062 · DOI
- KA Schaefer, 2017, Unexpected mutations after CRISPR-Cas9 editing in vivo, Nature Methods, 14, 547, 10.1038/nmeth.4293 · DOI · Paper page
Cited by
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
Self-citationTranscriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Konermann, S., Lotfy, P., Brideau, N. J., Oki, J., Shokhirev, M. N., & Hsu, P. D. (2018) · Cell · doi:10.1016/j.cell.2018.02.033 · Cited by 1,164
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., Sausville, E. L., Lukow, D. A., Liu, L., Chait, A. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8412 · Cited by 754
Synthetic lethality as an engine for cancer drug target discovery
Huang, A., Garraway, L. A., Ashworth, A., & Weber, B. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0046-z · Cited by 469
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Kantor, A., McClements, M., & MacLaren, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176240 · Cited by 462
Metadata
- Authors
- Smith, I., Greenside, P. G., Natoli, T., Lahr, D. L., Wadden, D., Tirosh, I., Narayan, R., Root, D. E., Golub, T. R., Subramanian, A., & Doench, J. G.
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-30
- Volume
- 15
- Issue
- 11
- Pages
- e2003213
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- OpenAlex
- W2950461129
- Cited by
- 194
- References
- 20
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Update notices
- new_version (2017-12-12)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.